NCT04316078View on ClinicalTrials.gov

A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies

NACompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

July 15, 2021

Study Completion Date

April 15, 2022

Conditions

Colon CancerGastric CancerPancreas CancerRectal CancerCholangiocarcinomaSmall Bowel CancerEsophageal Cancer

Interventions

OTHER

patient engagement platform

"1. Allows patients to receive the action plan as educational videos on demand.~2. Allows patients to report side effects and quality of life via questionnaires and receive immediate targeted education based on the predefined action plan."

Trial Locations (1)

52621

Sheba Medical Center, Ramat Gan

All Listed Sponsors

lead

Sheba Medical Center

OTHER_GOV

NCT04316078 - A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies | Biotech Hunter | Biotech Hunter